Astral Other Announcement
Designated Person Santoshkumar Pandey sold 1,724 equity shares of Astral Ltd for Rs. 0.27 Crore via a market sale.
- Value
- ₹0.27 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Designated Person Santoshkumar Pandey sold 1,724 equity shares of Astral Ltd for Rs. 0.27 Crore via a market sale.
Astral Limited held its 30th Annual General Meeting on August 24, 2026. Shareholders considered financial statements, dividends, and director re-appointments.
Astral delivered a robust 15.9% revenue growth and 15.5% consolidated EBITDA margin, significantly outperforming a sluggish polymer industry that contracted 10%. Growth was driven by adhesives and paints, despite flat plumbing volumes.
Astral Limited released its Q1 2026-27 financial highlights, reporting consolidated revenue growth of 15.9% and EBITDA growth of 25.8%. The update also provided business segment performance.
Astral Ltd reported revenue from operations of ₹1,578 Cr (+15.9% YoY) and net profit of ₹120.2 Cr (+51.8% YoY) for Q1 FY27.
Astral Limited will hold a board meeting on 12th August, 2026, to approve the company's unaudited financial results for the quarter ended 30th June, 2026.
Astral Limited has set August 14, 2026, as the record date for determining shareholder entitlement to a final dividend of Rs. 2.50 per equity share.
Astral Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 as per SEBI (LODR) regulations.
Astral Limited has filed its Annual Report for FY 2025-26 and the Notice for its 30th Annual General Meeting scheduled for August 24, 2026.
Astral Limited has scheduled its 30th Annual General Meeting on August 24, 2026, via video conferencing to transact ordinary and special business matters.
Astral Limited's Board decided to withdraw the proposed Composite Scheme of Arrangement for the demerger of its Chemical Business, following an independent review.